Form 4 for XERS Xeris Biopharma Holdings, Inc.
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001867096-22-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-24 | 2022-02-22 | XERS | PRESTRELSKI STEVEN | CSO | M - OptEx | $0.69 | +11.2K | 581.0K | +2% | +$7,747 |
| D | 2022-02-24 | 2022-02-22 | XERS | PRESTRELSKI STEVEN | CSO | S - Sale+OE | $2.42 | -11.2K | 569.8K | -2% | -$27.2K |
| D | 2022-02-24 | 2022-02-22 | XERS | PRESTRELSKI STEVEN | CSO | M - OptEx | $0.00 | -11.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | M | A | 11,228 | $0.69 | 581,008 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-22 | S | D | 11,228 | $2.42 | 569,780 | D | — | — | (F2) $2.4188 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.36 to $2.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-22 | M | D | 11,228 | $0.00 | 0 | D | $0.69 · 2022-02-22 to 2022-02-23 | 11,228 Common Stock | (F3) These options are fully vested as of the date hereof. |